Cell Therapeutics, Inc.'s ticker is CTIC and the CUSIP is 150934503. A total of 1 filers reported holding Cell Therapeutics, Inc. in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | – | 800 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 800 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,000 | -50.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | -33.3% | 800 | -50.0% | 0.00% | 0.0% |
| Q1 2015 | $3,000 | +50.0% | 1,600 | +100.0% | 0.00% | 0.0% |
| Q4 2014 | $2,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $2,000 | -33.3% | 800 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $3,000 | +50.0% | 800 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $2,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Investment Advisors, LLC | 800 | $0 | 0.00% |